<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03395548</url>
  </required_header>
  <id_info>
    <org_study_id>29-255 ex 16/17</org_study_id>
    <nct_id>NCT03395548</nct_id>
  </id_info>
  <brief_title>Stability of the Microbiome in IBD and IBS</brief_title>
  <official_title>Stability of the Intestinal Microbiome in Patients Suffering From Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS) Under the Influence of an Osmotic Laxans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the investigators aim to investigate the changes of the intestinal microbiome
      in three different cohorts (IBD, IBS, healthy) after applying the uniform disruptive factor
      of osmotic diarrhea induced by macrogol. The investigators hypothesis is that ill people will
      show more severe changes of the microbiome than healthy people and that these changes persist
      longer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      I
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 25, 2017</start_date>
  <completion_date type="Anticipated">November 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes of the microbiome</measure>
    <time_frame>4 months</time_frame>
    <description>The investigators aim to asses the changes of the gut microbiome between the three Groups and before and after lavage (Alpha Diversity, Beta Diversity, Group Significance)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Microbiota</condition>
  <arm_group>
    <arm_group_label>Inflammatory bowel disease</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The aim is to recruit 20 persons suffering from Crohn's disease or ulcerative colitis with stable medication and stable control of the disease.
As in each group the intervention will be the colon lavage with macrogol in combination with the colonoscopy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Irritable bowel syndrome</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The aim is to recruit 20 persons suffering from irritable bowel syndrome (IBS) fulfilling rome criteria.
As in each group the intervention will be the colon lavage with macrogol in combination with the colonoscopy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The aim is to recruit 20 persons without known illnesses with a comparable age to the other two groups.
As in each group the intervention will be the colon lavage with macrogol in combination with the colonoscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Macrogol</intervention_name>
    <description>Used drug: Macrogol (osmotic laxative)</description>
    <arm_group_label>Inflammatory bowel disease</arm_group_label>
    <arm_group_label>Irritable bowel syndrome</arm_group_label>
    <arm_group_label>Healthy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with inflammatory bowel disease and irritable bowel syndrome and stable
             therapy since three months

          -  patients with the indication for colonoscopy

        Exclusion Criteria:

          -  age under 18

          -  pregnancy

          -  new therapy planned

          -  change of therapy within the last three months

          -  acute exacerbation of the inflammatory bowel disease

          -  colon pathologies of other origin: colocarcinoma, Illnesses with diarrhea
             (f.e.microscopic colitis), short bowel syndrome, malabsorption, colectomy

          -  intake of antibiotics in the last three months

          -  intake of probiotics in the last month

          -  intake of antibiotics or probiotics during the study

          -  new proton pump inhibitor therapy

          -  significant change of nutrition in the last three months

          -  holidays outside europe in the last month

          -  gastroenteritis in the last three months

          -  intake of laxatives

          -  nonsteroidal antiinflammatory drugs should be avoided and documented
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Blesl, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Graz</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andreas Blesl, MD</last_name>
    <phone>004338580989</phone>
    <email>andreas.blesl@medunigraz.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christoph Hoegenauer, Prof.</last_name>
    <email>christoph.hoegenauer@medunigraz.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universit√§tsklinikum Graz</name>
      <address>
        <city>Graz</city>
        <state>Styria</state>
        <zip>8010</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Blesl, MD</last_name>
      <phone>004338580989</phone>
      <email>andreas.blesl@medunigraz.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2017</study_first_submitted>
  <study_first_submitted_qc>January 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 10, 2018</study_first_posted>
  <last_update_submitted>January 3, 2018</last_update_submitted>
  <last_update_submitted_qc>January 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

